Literature DB >> 21362071

HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction.

M Andrassy1, H C Volz, N Riedle, G Gitsioudis, C Seidel, D Laohachewin, A R Zankl, Z Kaya, A Bierhaus, E Giannitsis, H A Katus, G Korosoglou.   

Abstract

OBJECTIVES: High-mobility group box 1 (HMGB1) protein is an innate danger signal for the initiation of host defence and tissue repair. The aim of this study was to analyse serum HMGB1 concentration and its correlation with infarct transmurality and functional recovery in patients with ST-elevation (STEMI) and non-ST-elevation myocardial infarction (NSTEMI).
DESIGN: We prospectively examined patients with first-time STEMI (n = 46) or NSTEMI (n = 49), treated according to current guidelines. Contrast-enhanced cardiac magnetic resonance imaging was performed 2-4 days after infarction for the estimation of infarct transmurality and was repeated after 6 months for the estimation of residual left ventricular function. HMGB1 was measured 2-4 days after infarction.
RESULTS: High-mobility group box 1 concentration was related to infarct size and to residual ejection fraction in patients with STEMI (r(2) = 0.81 and r(2) =0.40, respectively, P < 0.001 for both) and NSTEMI (r(2) = 0.74 and r(2) = 0.25, respectively, P < 0.001 for both). Receiver operating characteristic (ROC) curve-derived cut-off values of 6.2 and 5.9 ng mL(-1) for patients with STEMI and NSTEMI, respectively, were predictive of infarct transmurality greater than 75% (STEMI: area under the curve (AUC) = 0.93, standard error (SE) = 0.04, 95% confidence interval (CI) = 0.81-0.98; NSTEMI: AUC = 0.96, SE = 0.04, 95% CI = 0.86-0.99). HMGB1 cut-off values of 7.2 and 6.4 ng mL(-1) for patients with STEMI and NSTEMI, respectively, were predictive of residual ejection fraction 6 months after myocardial infarction (MI) (STEMI: AUC = 0.81, SE = 0.07, 95% CI = 0.66-0.91; NSTEMI: AUC = 0.81, SE = 0.09, 95% CI = 0.68-0.91).
CONCLUSION: High-mobility group box 1 serum levels represent a highly valuable surrogate marker for infarct transmurality and for the prediction of residual left ventricular function after MI.
© 2011 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21362071     DOI: 10.1111/j.1365-2796.2011.02369.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  27 in total

Review 1.  Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.

Authors:  G A Ramirez; N Maugeri; M G Sabbadini; P Rovere-Querini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

Review 2.  Assessment of coronary artery disease using coronary computed tomography angiography and biochemical markers.

Authors:  Gitsios Gitsioudis; Hugo A Katus; Grigorios Korosoglou
Journal:  World J Cardiol       Date:  2014-07-26

Review 3.  Resident and Monocyte-Derived Macrophages in Cardiovascular Disease.

Authors:  Lisa Honold; Matthias Nahrendorf
Journal:  Circ Res       Date:  2018-01-05       Impact factor: 17.367

4.  Critical role of RAGE and HMGB1 in inflammatory heart disease.

Authors:  Anna Bangert; Martin Andrassy; Anna-Maria Müller; Mariella Bockstahler; Andrea Fischer; Christian H Volz; Christoph Leib; Stefan Göser; Sevil Korkmaz-Icöz; Stefan Zittrich; Andreas Jungmann; Felix Lasitschka; Gabriele Pfitzer; Oliver J Müller; Hugo A Katus; Ziya Kaya
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-29       Impact factor: 11.205

5.  Transforming growth factor β-activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling.

Authors:  Lei Li; Yi Chen; Jessica Doan; Jason Murray; Jeffery D Molkentin; Qinghang Liu
Journal:  Circulation       Date:  2014-10-02       Impact factor: 29.690

Review 6.  Serum glycated albumin is superior to hemoglobin A1c for correlating with HMGB1 in coronary artery disease with type 2 diabetic mellitus patients.

Authors:  Jianjun Yin; Daoqun Jin; Hong Wang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 7.  Receptor for advanced glycation end products (RAGE) and implications for the pathophysiology of heart failure.

Authors:  Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Curr Heart Fail Rep       Date:  2012-06

8.  Anti-inflammatory effect of B-type natriuretic peptide postconditioning during myocardial ischemia-reperfusion: involvement of PI3K/Akt signaling pathway.

Authors:  Gangying Hu; Xingyue Huang; Kai Zhang; Hong Jiang; Xiaorong Hu
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

9.  Anti-inflammatory effect of exendin-4 postconditioning during myocardial ischemia and reperfusion.

Authors:  Xianjin Du; Xiaorong Hu; Jie Wei
Journal:  Mol Biol Rep       Date:  2014-02-19       Impact factor: 2.316

Review 10.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.